Comparison of 68Ga-DOTANOC PET/CT with cardiac MRI in patients with clinical suspicion of cardiac sarcoidosis

[1]  D. Alis,et al.  Diagnostic values of edema-sensitive T2-weighted imaging, TSE T1-weighted early contrast-enhanced imaging, late gadolinium enhancement, and the Lake Louise criteria in assessing acute myocarditis: A single-center cardiac magnetic resonance study. , 2020, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[2]  R. Blankstein,et al.  Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study , 2019, Journal of Nuclear Cardiology.

[3]  Hyuk-Jae Chang,et al.  Recent Advances in Cardiac Magnetic Resonance Imaging , 2018, Korean circulation journal.

[4]  R. Slart,et al.  Somatostatin receptor based hybrid imaging in sarcoidosis , 2017, European Journal of Hybrid Imaging.

[5]  M. Essler,et al.  Cardiovascular magnetic resonance imaging and clinical performance of somatostatin receptor positron emission tomography in cardiac sarcoidosis , 2017, ESC heart failure.

[6]  F. Terasaki,et al.  New Guidelines for Diagnosis of Cardiac Sarcoidosis in Japan , 2017 .

[7]  W. Bauer,et al.  Somatostatin receptor based PET/CT in patients with the suspicion of cardiac sarcoidosis: an initial comparison to cardiac MRI , 2016, Oncotarget.

[8]  L. Gormsen,et al.  A dual tracer 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT pilot study for detection of cardiac sarcoidosis , 2016, EJNMMI Research.

[9]  K. Togashi,et al.  The utility of PET/CT with 68Ga-DOTATOC in sarcoidosis: comparison with 67Ga-scintigraphy , 2016, Annals of Nuclear Medicine.

[10]  M. Miyagawa,et al.  Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis. , 2015, International journal of cardiology.

[11]  E. Miller,et al.  Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis , 2014, Journal of Nuclear Cardiology.

[12]  C. Catalano,et al.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. , 2014, JACC. Cardiovascular imaging.

[13]  E. Leung,et al.  The role of F18-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis , 2013, Journal of Nuclear Cardiology.

[14]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[15]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[16]  S. Lamberts,et al.  Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas , 1999, European journal of clinical investigation.

[17]  D. Pennell,et al.  Recent advances in cardiac magnetic resonance imaging. , 1996, Current opinion in cardiology.

[18]  A. Patchefsky,et al.  The automated implantable cardiac defibrillator. Prophylaxis in cardiac sarcoidosis. , 1994, Chest.

[19]  Y. Kawabata,et al.  Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern , 1993, Acta pathologica japonica.

[20]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .